ArticleDigestive diseases and sciences2025

Rifaximin-Alpha Increases Lactase Activity in Patients with Irritable Bowel Syndrome Without Constipation and Small Intestinal Bacterial Overgrowth.

María Fernanda García-Cedillo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.